VI
RGEN icon

Versor Investments’s Repligen RGEN Stock Holding History

Versor Investments’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,232
Closed -$1.02M – 869
2025
Q2 		$1.02M Sell
8,232
-2,212
-21% -$281K 0.18% 162
2025
Q1 		$1.33M Buy
10,444
+7,077
+210% +$1.09M 0.22% 119
2024
Q4 		$485K Sell
3,367
-2,634
-44% -$378K 0.08% 397
2024
Q3 		$893K Buy
+6,001
New +$860K 0.14% 233
2024
Q2 		– Sell
-1,544
Closed -$284K – 898
2024
Q1 		$284K Buy
+1,544
New +$294K 0.06% 515
2022
Q4 		– Sell
-1,400
Closed -$262K – 936
2022
Q3 		$262K Sell
1,400
-2,600
-65% -$548K 0.02% 648
2022
Q2 		$650K Buy
4,000
+976
+32% +$154K 0.02% 394
2022
Q1 		$569K Buy
+3,024
New +$574K 0.02% 284

Other funds holding RGEN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $18.2B AUM 22.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Versor Investments's RGEN Position: Q3 2025 in Review

Versor Investments sold out of Repligen (RGEN) in Q3 2025, closing a stake of 8,232 shares — an estimated $1.02M sold.

Versor Investments first reported a position in RGEN in Q1 2022 and held it in 8 quarters. The position peaked at $1.33M in Q1 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Versor Investments reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Versor Investments sold 8,232 Repligen shares in Q3 2025, an estimated $1.02M.
  • Versor Investments first reported a position in Repligen in Q1 2022 and held it in 8 quarters.
  • Versor Investments's Repligen position peaked at $1.33M in Q1 2025.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Versor Investments's 13F filing for Q3 2025, filed 6 Nov 2025.